Complete Conference Management 30th Annual Heart Failure 2026
$30.00
This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!
Complete Conference Management 30th Annual Heart Failure 2026
Advanced Heart Failure, Cardiomyopathy & Contemporary Cardiovascular Therapy Update
Overview
The Complete Conference Management 30th Annual Heart Failure 2026 program is a comprehensive cardiovascular CME conference dedicated to the modern management of heart failure, cardiomyopathies, structural heart disease, and advanced cardiovascular therapies.
Celebrating its 30th anniversary, this highly respected educational symposium brings together leading experts in heart failure, interventional cardiology, electrophysiology, cardiovascular imaging, nephrology, and preventive cardiology to review the latest evidence-based strategies for improving outcomes in patients with acute and chronic heart failure.
The program emphasizes practical clinical decision-making, guideline-directed medical therapy (GDMT), advanced diagnostics, catheter-based interventions, cardiogenic shock management, cardiorenal syndromes, and emerging therapies that are reshaping cardiovascular care.
Package Includes
Format
- 8 Video Lectures
- 8 Subtitle Files (VTT)
- 29 PDF Presentations
Total Size
5.99 GB
Educational Level
Advanced
Specialty
Heart Failure & Cardiovascular Medicine
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply current guideline-directed medical therapy (GDMT) for heart failure.
- Optimize management of HFrEF and HFpEF.
- Evaluate and manage acute decompensated heart failure.
- Recognize and treat cardiogenic shock.
- Integrate cardiorenal management strategies into practice.
- Develop treatment plans for hypertrophic cardiomyopathy and cardiac amyloidosis.
- Manage atrial fibrillation in heart failure patients.
- Understand catheter-based therapies for structural heart disease.
- Apply current approaches to pulmonary arterial hypertension.
- Improve cardiovascular risk reduction and prevention strategies.
Core Topics Covered
Guideline-Directed Medical Therapy (GDMT)
Topics Include
- Current Heart Failure Guidelines
- HFrEF Treatment
- HFpEF Treatment
- Quadruple Therapy Optimization
- Medication Titration Strategies
- Evidence-Based Algorithms
Focus on implementation of modern heart failure pharmacotherapy.
Heart Failure With Reduced Ejection Fraction (HFrEF)
Topics Include
- Neurohormonal Blockade
- SGLT2 Inhibitors
- ARNI Therapy
- Beta Blockers
- Mineralocorticoid Receptor Antagonists
- Long-Term Outcome Improvement
Review of contemporary treatment approaches.
Heart Failure With Preserved Ejection Fraction (HFpEF)
Topics Include
- Diagnostic Challenges
- Emerging Therapies
- Comorbidity Management
- Obesity and HFpEF
- Evidence-Based Treatment Strategies
Discussion of one of the fastest evolving areas in cardiovascular medicine.
Acute Decompensated Heart Failure
Topics Include
- Hospital Management
- Diuretic Strategies
- Hemodynamic Stabilization
- Risk Stratification
- Discharge Planning
Practical recommendations for inpatient and transitional care.
Cardiogenic Shock
Topics Include
- Recognition and Classification
- Hemodynamic Assessment
- Mechanical Circulatory Support
- Escalation of Care
- Advanced Shock Management
Review of modern shock treatment algorithms.
Advanced Heart Failure Therapies
Topics Include
- Referral Criteria
- Mechanical Circulatory Support
- Left Ventricular Assist Devices (LVAD)
- Heart Transplantation
- Advanced Care Planning
Focus on identifying appropriate candidates for advanced therapies.
Cardiomyopathies
Hypertrophic Cardiomyopathy
Topics Include
- Diagnosis
- Genetic Evaluation
- Risk Stratification
- Novel Medical Therapies
- Septal Reduction Strategies
Cardiac Amyloidosis
Topics Include
- Early Recognition
- Imaging Diagnosis
- ATTR Amyloidosis
- AL Amyloidosis
- Emerging Treatments
One of the major highlights of the conference.
Heart Failure & Kidney Disease
Topics Include
- Cardiorenal Syndrome
- CKD Management
- Renal Protection
- Medication Selection
- Integrated Heart-Kidney Care
Review of multidisciplinary approaches to cardiorenal disease.
Arrhythmias in Heart Failure
Topics Include
- Atrial Fibrillation
- Rhythm Control
- Rate Control
- Anticoagulation
- Device-Based Therapy
Discussion of arrhythmia management in complex heart failure populations.
Valvular Heart Disease
Topics Include
- Structural Heart Disease
- TAVR
- Mitral Valve Interventions
- Catheter-Based Procedures
- Patient Selection
Focus on contemporary structural heart therapies.
Pulmonary Hypertension
Topics Include
- Pulmonary Arterial Hypertension
- Right Ventricular Failure
- Diagnostic Evaluation
- Advanced Therapies
Review of pulmonary vascular disease in heart failure populations.
Special Populations
Topics Include
- Obesity and Heart Failure
- Peripartum Cardiomyopathy
- Myocarditis
- Geriatric Heart Failure Patients
- Complex Multimorbidity
Prevention & Risk Reduction
Topics Include
- Hypertension Management
- Hyperlipidemia Treatment
- Cardiovascular Prevention
- Early Detection of Heart Failure
- Lifestyle Interventions
Focus on reducing long-term cardiovascular morbidity and mortality.
Educational Highlights
Expert Faculty
Internationally recognized heart failure and cardiovascular specialists.
Evidence-Based Updates
Current guidelines integrated with the latest clinical trial data.
Practical Clinical Focus
Designed for immediate application in clinical practice.
Multidisciplinary Approach
Combines perspectives from cardiology, nephrology, electrophysiology, imaging, and structural heart disease.
Target Audience
Physicians
- Cardiologists
- Advanced Heart Failure Specialists
- Internists
- Primary Care Physicians
- Intensivists
- Hospitalists
Advanced Practice Providers
- Nurse Practitioners
- Physician Assistants
Allied Health Professionals
- Pharmacists
- Nurses
- Cardiovascular Care Professionals
Why This Course Stands Out
✔ 30 years of heart failure education excellence
✔ Comprehensive HFrEF and HFpEF updates
✔ Strong emphasis on GDMT implementation
✔ Advanced cardiomyopathy and amyloidosis coverage
✔ Cardiogenic shock and mechanical support education
✔ Structural heart disease interventions
✔ Cardiorenal syndrome management
✔ Contemporary pulmonary hypertension updates
✔ Practical evidence-based recommendations
✔ Multidisciplinary cardiovascular approach
4. Topics
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
-
Case Discussions
-
Product Theatre Breakfast – Non-CME Navigating Fabry Disease
-
SESSION I
-
SESSION II
-
SESSION III
-
SESSION IV
-
SESSION V
-
SESSION VI
* Detail:
FRIDAY, March 13, 2026
- 11:00am-12:00pm Registration, Coffee, Visit Exhibits
- 12:00-1:00pm Product Theatre Luncheon – Non-CME Evidence – Based Treatment of Recurrent Pericarditis Mariko Harper, MD, MS, FACC Supported by: Kiniksa
- 1:00-1:15pm Coffee Break and Visit Exhibits
- SESSION I
- 1:15-1:25pm Introduction to the 30th Annual Symposium: Heart Failure 2026 – An Update on Therapy Uri Elkayam, MD, FACC
- 1:25-1:45pm Management of the Hospitalized Patients with Decompensated Heart Failure Uri Elkayam, MD, FACC
- 1:45-2:05pm Balancing GDMT and Hyperkalemia Ileana L. Piña, MD
- 2:05-2:25pm Digitoxin in Heart Failure: A Comeback for Digitalis? Tien Ng, PharmD
- 2:25-2:45pm Introducing Finerenone: A New Drug for the Management of Heart Failure and Chronic Kidney Disease Akshay Desai, MD
- 2:45-3:05pm Vericiguat in Heart Failure: When and How to Use It Barry Greenberg, MD
- 3:05-3:25pm The Contemporary Management of HFpEF Akshay Desai, MD
- 3:25-3:40pm Coffee Break and Visit Exhibits
- SESSION II
- 3:40-4:00pm Our Journey with Diuretics: 240 Years, and How Far Have We Come? Marvin Konstam, MD
- 4:00-4:20pm Treating Congestion in Patients with Acute Decompensated Heart Failure: Where Are We Now? Where Are We Going? William Abraham, MD
- 4:20-4:40pm Releasing the Brakes on the Immune System in Cancer: Implications in Myocarditis and Beyond Eric Yang, MD
- 4:40-5:00pm Clinical Experience with the Use of Myosin Inhibitors in the Treatment of Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy Jessica Wang, MD
- 5:00-5:20pm Contemporary Management of Obesity in Patients with Heart Failure Norman Lepor, MD
- 5:20pm Adjourn
SATURDAY, March 14, 2026
- 7:00am Registration Open
- 7:15-7:45am Case Discussion Uri Elkayam, MD and Barry Greenberg, MD
- 7:45-8:45am Product Theatre Breakfast – Non-CME Navigating Fabry Disease Dr. Anjay Rastogi Supported by: Sanofi
- 8:45-9:00am Break and Visit the Exhibits
- SESSION III
- 9:00-9:15am Introduction to Day Two: 30th Annual Symposium: Heart Failure 2026 – An Update on Therapy Uri Elkayam, MD
- 9:15-9:35am GDMT for Chronic HFrEF: How to Maximize the Benefits? Gregg Fonarow, MD
- 9:35-9:55am Cardiogenic Shock: Hemodynamic Classification and Management Rola Khedraki, MD
- 9:55-10:15am Percutaneous Coronary Interventions in Ischemic Cardiomyopathy – Does It Work? Christina Economides, MD
- 10:15-10:35am Bio-Omics in Heart Failure Diagnosis and Therapy Kirkwood Adams, MD
- 10:35-10:55am Break and Visit the Exhibits
- SESSION IV
- 10:55-11:15am Genetic Testing for Cardiomyopathy Josh Hare, MD
- 11:15-11:35am Gene Therapy for Patients with Cardiomyopathy Barry Greenberg, MD
- 11:35-11:55am Stem Cell Therapy for the Management of Myocardial Disease: A Status Report Josh Hare, MD
- 11:55-12:15pm Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy Uri Elkayam, MD
- 12:15-12:35pm Update on the Management of Atrial Fibrillation in Patients with Heart Failure Anil Bhandari, MD
- 12:35-1:35pm Product Theatre Luncheon – Non-CME Pivotal Trial and Cardiac Structure and Function Outcomes With CAMZYOS® in Patients With Symptomatic NYHA Class II-III Obstructive HCM Florian Rader, MD Supported by: Bristol Myers Squibb
- 1:35-1:50pm Break and Visit the Exhibits
- SESSION V
- 1:50-2:20pm KEYNOTE LECTURE 30 Years of Innovation in the Management of Heart Failure: A Perspective Clyde Yancy, MD
- 2:20-2:40pm Bromocriptine in the Management of Peripartum Cardiomyopathy: Pathophysiologic Mechanism and Available Data Uri Elkayam, MD
- 2:40-3:00pm What Is New in Myocarditis: An Update from the ESC 2025 Guidelines Leslie Cooper, MD
- 3:00-3:20pm Pulmonary Hypertension: New Drugs and How to Use Them Thomas Heywood, MD
- 3:20-3:40pm Innovations in Device Therapy for Heart Failure William Abraham, MD
- 3:40-4:00pm Break and Visit Exhibits
- SESSION VI
- 4:00-4:20pm The Use of AI in the Management of Heart Failure Nir Uriel, MD
- 4:20-4:40pm Autonomic Modulation in Heart Failure Treatment: Where Are We and Where Are We Heading? Marvin Konstam, MD
- 4:40-5:00pm LVAD vs Heart Transplantation: A Perspective Nir Uriel, MD
- 5:00-5:20pm Individual Selection of Drug Therapy in Patients with Transthyretin (TTR) Amyloidosis Mazen Hanna, MD
- 5:20pm Adjourn
Related products
Critical Care - Emergency medicine
Critical Care - Emergency medicine
Critical Care - Emergency medicine
Critical Care - Emergency medicine
USMLE / kaplan and Board Review
Uworld USMLE COMLEX Level 1 Qbank, Updated Jan 2023, System- and Subject-wise (PDF)
Medical Accounts
Family medicine
Cardiology